The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Regulus Therapeutics Inc(NASDAQ:RGLS) 
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the trea...
Website: http://www.regulusrx.com
Founded: 2007
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
Regulus Therapeutics Days Payable Outstanding ttm (DPO)
Regulus Therapeutics Days Receivable Outstanding ttm (DSO)
Regulus Therapeutics Op Cashflow Per Share ttm
Regulus Therapeutics Free Cashflow Per Share ttm
Regulus Therapeutics Cash Per Share ttm
Regulus Therapeutics P/S ratio ttm
Regulus Therapeutics (GAAP) P/E ratio ttm
Regulus Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.